Zenas BioPharma Ownership | Who Owns Zenas BioPharma?
Zenas BioPharma Ownership Summary
Zenas BioPharma is owned by 81.34% institutional investors, 21.20% insiders. Nea management company is the largest institutional shareholder, holding 6.53% of ZBIO shares.
ZBIO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Zenas BioPharma | 81.34% | 21.20% | -2.54% |
Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Nea management company | 2.73M | 6.53% | $26.49M |
Novo | 2.25M | 5.37% | $21.80M |
Fairmount funds management | 1.89M | 4.52% | $18.34M |
Nvp associates | 1.84M | 4.39% | $17.81M |
Deerfield management company, l.p. (series c) | 1.56M | 3.73% | $15.14M |
Vivo capital | 1.18M | 2.83% | $11.47M |
Blackrock funding, inc. /de | 1.10M | 2.62% | $10.62M |
Arrowmark colorado | 1.09M | 2.61% | $10.60M |
Pivotal bioventure partners investment advisor | 779.04K | 1.86% | $7.55M |
Rock springs capital management lp | 640.47K | 1.53% | $6.21M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Nvp associates | 1.84M | 9.67% | $17.81M |
Pivotal bioventure partners investment advisor | 779.04K | 4.68% | $7.55M |
Fairmount funds management | 1.89M | 2.38% | $18.34M |
Nea management company | 2.73M | 1.99% | $26.49M |
Novo | 2.25M | 1.54% | $21.80M |
Sectoral asset management | 210.63K | 1.35% | $2.04M |
Superstring capital management lp | 111.61K | 1.28% | $1.08M |
Vivo capital | 1.18M | 1.17% | $11.47M |
Rock springs capital management lp | 640.47K | 0.39% | $6.21M |
Eversept partners, lp | 325.48K | 0.29% | $3.15M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Sectoral asset management | 210.63K | 1.35% | 210.63K |
Nea management company | 2.73M | 1.99% | 119.77K |
Blackrock funding, inc. /de | 1.10M | 0.00% | 81.50K |
Pivotal bioventure partners investment advisor | 779.04K | 4.68% | 42.40K |
Novo | 2.25M | 1.54% | 35.03K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Perceptive advisors | - | - | -744.03K |
Rock springs capital management lp | 640.47K | 0.39% | -238.20K |
Millennium management | - | - | -134.90K |
Eversept partners, lp | 325.48K | 0.29% | -120.11K |
M&t bank | - | - | -62.62K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Sectoral asset management | 210.63K | 1.35% | 210.63K | $2.04M |
Alpine global management | 12.91K | 0.03% | 12.91K | $125.07K |
Quarry lp | 843.00 | 0.00% | 843.00 | $8.17K |
Physician wealth advisors | 67.00 | 0.00% | 67.00 | $650.00 |
Clearstead advisors | 23.00 | - | 23.00 | $223.00 |
Sold Out
Holder | Change |
---|---|
Mrp capital investments | -35.00 |
Corebridge financial | -7.53K |
Stoneridge investment partners | -10.96K |
Two sigma investments, lp | -17.05K |
Gsa capital partners llp | -31.76K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 72 | 12.50% | 34,055,191 | 22.15% | 81 | 1.83% | 47 | 67.86% | 11 | -45.00% |
Mar 31, 2025 | 66 | 4.76% | 32,487,083 | 3.18% | 77 | 13.66% | 27 | -42.55% | 20 | 233.33% |
Dec 31, 2024 | 64 | 48.84% | 31,696,956 | 28.35% | 24 | 0.69% | 48 | 11.63% | 6 | - |
Sep 30, 2024 | 43 | - | 24,696,152 | - | 59 | - | 43 | - | - | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 07, 2025 | Xiao Ting | - | Buy | $77.60K |
Feb 18, 2025 | MOULDER LEON O JR | Chief Executive Officer | Buy | $166.75K |
Feb 07, 2025 | Xiao Ting | - | Buy | $77.60K |
Dec 03, 2024 | MOULDER LEON O JR | Chief Executive Officer | Buy | $269.00K |
Dec 04, 2024 | MOULDER LEON O JR | Chief Executive Officer | Buy | $449.10K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | 2 | - |
2024 Q4 | 4 | - |
ZBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools